Changing Demographics: Nurturing humanity
Global population growth
Variable quality of care
Large variance in cancer survival rates globally, e.g. ~8x variance for stomach cancer
Unmet patient needs
¼ of all deaths are premature - and there - 95% of rare diseases lack FDA-approved treatments
Rising healthcare costs
Costs are growing at 1-2 p.p. above GDP - 30%+ of expenditure is estimated to be waste in advanced healthcare systems
The study of all molecules in the human biology system, covering a large family of cellular molecules - e.g. genes, proteins, or small metabolites
2 Synthetic biology
Synthetic biology is the combination of science and engineering to construct new biological entities and redesign existing ones
3 Healthcare analytics
Healthcare analytics is the use of data and statistics to enable a more efficient and higher quality healthcare
- Mass Spec tools and services
- Detection (NGS, PCR, Microarray)
- Sequencing and 3D analysis of protein structures
- Oligo synthesis companies
- Viral vectors
- Cell and Gene Therapy
- Genetic engineering
- Artificial cells
- Tissue engineering
- Organ printing
- Personalized health journeys
- Smarter diagnostics
- Activity data from smart wearables
- Treatment adherence monitoring
- Big data analytics
- Real world evidence
Technologies Analytical software Services
Each of these domains encompass a large and dynamic ecosystem with many sub-sectors and market niches. Summa screens for the most relevant investable niches within these ecosystems through deep-dive analysis of sub-sectors.
In the early days of my business degree, I always regretted not studying medicine instead. I did not have the guts to change and follow my heart. Since then I changed my strategy to focus on the things that inspire me and that I think are really important. The strategy we deploy in healthcare at Summa makes me hope for the future. Now more than ever, we need our healthcare systems to be resilient and provide better health at a sustainable cost. Investing in companies that can help nudge our healthcare systems in the right direction is a humbling and inspiring task.
- — We want to invest in businesses that create an impact in healthcare. Furthering our understanding of biology, creating tools to drive better outcomes or better decision making, and finding better ways to deliver health are important things.
- — The world has seen its first global health crisis in modern times. It caught most of us off guard, and everyone has been affected in some way. How will our societies and health systems adapt, and how do we move forward knowing that this will not be the last time? These are big questions and answers are complex. However, I do know we need better solutions for individual and public health, and systems that are more resilient.
- — System change is required to have more sustainable health systems. Healthcare needs to become more predictive, preventive, and personalised.
- — The fundamentals are what drive us. We believe in people, in technology and in ideas. Our job is to enable those with the right solutions to scale and succeed. Simple as that.
- — Our team gets energy when we work with businesses that are fuelled by innovation, and that can drive new solutions at scale. The people that work with me know that my job is my hobby. I take this very seriously, but I am bent on having fun whilst doing this as well.
- —Our job is about collaboration and the enablement of people. Win-win is the only way to succeed over the long term.
- — The businesses that I have worked with that have become really successful all had true innovation as a basis for their success, and they had a plan that they pursued relentlessly. Their organisations were on a clear mission.
- — I’m glad that we are able to focus on companies that are driving important innovation in healthcare. This is a luxury.
Read more about Tommi here.